Cure My Disease

Don't miss your cure!

 Log in / Sign up

Targeted drug trial offers hope for men with Tough-to-Treat prostate cancer

NCT ID NCT02854436

Completed Disease control Sponsor: Janssen Research & Development, LLC Source: ClinicalTrials.gov ↗

Summary

This study tested whether the drug niraparib could help control advanced prostate cancer that had stopped responding to standard hormone therapies and had spread. It specifically enrolled 289 men whose cancer had specific problems with DNA repair, a genetic weakness the drug is designed to target. The main goal was to see how well the drug shrank tumors and how safe it was for these patients.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATIC NEOPLASMS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Study site

    Tucson, Arizona, United States

  • Study site

    Los Angeles, California, United States

  • Study site

    Riverside, California, United States

  • Study site

    Sacramento, California, United States

  • Study site

    Aurora, Colorado, United States

  • Study site

    Denver, Colorado, United States

  • Study site

    Evanston, Illinois, United States

  • Study site

    Danville, Kentucky, United States

  • Study site

    Louisville, Kentucky, United States

  • Study site

    New Orleans, Louisiana, United States

  • Study site

    Boston, Massachusetts, United States

  • Study site

    Detroit, Michigan, United States

  • Study site

    Omaha, Nebraska, United States

  • Study site

    New York, New York, United States

  • Study site

    Durham, North Carolina, United States

  • Study site

    Lancaster, Pennsylvania, United States

  • Study site

    Philadelphia, Pennsylvania, United States

  • Study site

    Myrtle Beach, South Carolina, United States

  • Study site

    Houston, Texas, United States

  • Study site

    Charlottesville, Virginia, United States

  • Study site

    Fairfax, Virginia, United States

  • Study site

    Seattle, Washington, United States

  • Study site

    Madison, Wisconsin, United States

  • Study site

    Camperdown, Australia

  • Study site

    Darlinghurst, Australia

  • Study site

    East Albury, Australia

  • Study site

    Kurralta Park, Australia

  • Study site

    Macquarie University, Australia

  • Study site

    Melbourne, Australia

  • Study site

    Murdoch, Australia

  • Study site

    Port Macquarie, Australia

  • Study site

    Randwick, Australia

  • Study site

    Wahroonga, Australia

  • Study site

    Aalst, Belgium

  • Study site

    Brussels, Belgium

  • Study site

    Charleroi, Belgium

  • Study site

    Ghent, Belgium

  • Study site

    Haine-Saint-Paul, Belgium

  • Study site

    Hasselt, Belgium

  • Study site

    Kortrijk, Belgium

  • Study site

    Liège, Belgium

  • Study site

    Namur, Belgium

  • Study site

    Ottignies, Belgium

  • Study site

    Wilrijk, Belgium

  • Study site

    Barretos, Brazil

  • Study site

    Belo Horizonte, Brazil

  • Study site

    Curitiba, Brazil

  • Study site

    Fortaleza, Brazil

  • Study site

    Ijuí, Brazil

  • Study site

    Itajaí, Brazil

  • Study site

    Joinville, Brazil

  • Study site

    Natal, Brazil

  • Study site

    Salvador, Brazil

  • Study site

    São Paulo, Brazil

  • Study site

    Vancouver, British Columbia, Canada

  • Study site

    Oshawa, Ontario, Canada

  • Study site

    Toronto, Ontario, Canada

  • Study site

    Montreal, Quebec, Canada

  • Study site

    Québec, Quebec, Canada

  • Study site

    Aarhus N, Denmark

  • Study site

    Copenhagen N, Denmark

  • Study site

    Herlev, Denmark

  • Study site

    Odense C, Denmark

  • Study site

    Avignon, France

  • Study site

    Besançon, France

  • Study site

    Caen, France

  • Study site

    Lyon, France

  • Study site

    Nice, France

  • Study site

    Paris, France

  • Study site

    Reims, France

  • Study site

    Strasbourg, France

  • Study site

    Villejuif, France

  • Study site

    Beersheba, Israel

  • Study site

    Haifa, Israel

  • Study site

    Kfar Saba, Israel

  • Study site

    Ramat Gan, Israel

  • Study site

    Zrifin, Israel

  • Study site

    Alkmaar, Netherlands

  • Study site

    Amsterdam, Netherlands

  • Study site

    Groningen, Netherlands

  • Study site

    Maastricht, Netherlands

  • Study site

    Rotterdam, Netherlands

  • Study site

    Moscow, Russia

  • Study site

    Omsk, Russia

  • Study site

    Tomsk, Russia

  • Study site

    Seoul, South Korea

  • Study site

    Barcelona, Spain

  • Study site

    Córdoba, Spain

  • Study site

    Madrid, Spain

  • Study site

    Málaga, Spain

  • Study site

    Pozuelo de Alarcón, Spain

  • Study site

    Santander, Spain

  • Study site

    Santiago de Compostela, Spain

  • Study site

    Seville, Spain

  • Study site

    Valencia, Spain

  • Study site

    Gothenburg, Sweden

  • Study site

    Lund, Sweden

  • Study site

    Stockholm, Sweden

  • Study site

    Umeå, Sweden

  • Study site

    Kaohsiung City, Taiwan

  • Study site

    Taichung, Taiwan

  • Study site

    Tainan, Taiwan

  • Study site

    Taipei, Taiwan

  • Study site

    Taoyuan, Taiwan

  • Study site

    Blackburn, United Kingdom

  • Study site

    Bristol, United Kingdom

  • Study site

    Cardiff, United Kingdom

  • Study site

    Exeter, United Kingdom

  • Study site

    London, United Kingdom

  • Study site

    Preston, United Kingdom

Conditions

Explore the condition pages connected to this study.

PROSTATIC NEOPLASMS